Keeping up with the constant advances in cancer research is like trying to climb a greased flagpole: It’s pretty much impossible. That’s particularly true given the diversity and breadth of the research being conducted.
The remarkable extent of that research is on full display in our most-read Cancer Currents stories published in 2022. Not surprisingly, readers are still very interested in the advances being made in immunotherapy, as well as topics like improving cancer screening and the role of artificial intelligence in diagnosis and treatment.
So, in case you missed them the first time around, here are our most-read stories of 2022 and some other noteworthy stories we’ve picked from the past year.
We’d like to thank you for your continued support of Cancer Currents. If you find our reporting important or helpful, please share our stories with friends and colleagues and encourage them to subscribe.
